Hypertension as a Risk Factor for Aspirin and Clopidogrel Resistance in Patients With Stable Coronary Artery Disease

Conclusion: We demonstrated higher incidence of antiplatelet resistance in patients with HT. Upon this finding, which is emerged from an actual group of patients with HT, cardioprotective effect of antiplatelet therapy in patients with HT should be argued.

http://cat.sagepub.com/cgi/content/abstract/20/7/749?rss=1

Source: Clinical and Applied Thrombosis/Hemostasis - August 26, 2014 Category: Hematology Authors: Akturk, I. F., Caglar, F. N., Erturk, M., Tuncer, N., Yalcın, A. A., Surgit, O., Uzun, F., Caglar, I. M. Tags: Original Articles Source Type: research